Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEACH trial: Adjuvant Lapatinib in HER2+ Breast Cancer
NCT00374322Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by GSK. Started Aug 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00374322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374322.